News By Tag Industry News News By Location Country(s) Industry News
| From molecule to medicine! - Novartis discuss dry powder inhalation at COPD 2015Now in its 7th year, the industry established conference on COPD will return to London on 19th and 20th October to discuss the latest advancements in Novel therapeutics and management strategies
By: SMi Group This years agenda will address questions such as: How does one reliably recruit and run clinical trials in a disease that branches to such extremes? What is the correct phenotype to measure in the disease? With the majority of COPD patients on varying courses of polypharmacy due to a range of different debilitating diseases alongside COPD – how can one find a clean patient? Highlights will include a keynote address from Dr Frank Thielmann, the Operational Lead in Inhalation New Solids from Novartis. The presentation on formulation development and manufacturing will discuss drug properties and challenges in the manufacturing of DPI systems, as well as provide unique insight into future trends in inhaled drug delivery. Other key speakers include: Philip Silkoff, Senior Medical Director, Johnson and Johnson Pharmaceutical Services LLC Stefano Petruzzelli, Chief Medical Officer and Director, Global Clinical Development, Chiesi Farmaceutici S.p.A Sanjeeva Dissanayake, Head of Medical Sciences – Respiratory, Mundipharma Noel Snell, Director of Research, British Lung Foundation Geoff Down, Chief Medical Officer, Prosonix Konstantinos Kostikas, Medical Director Respiratory COPD Region Europe, Novartis Pharma Thomas Schlange, Senior Biomarker Expert, Bayer Matthew Sleeman, Senior Director of Biology, Respiratory, Inflammation and Autoimmunity, MedImmune For those who are interested in attending there is currently a £400 discount available online. For further details visit the website. COPD 19th & 20th October 2015 Holiday Inn Regents Park Hotel, London UK http://www.smi- Sponsored by Quintiles ---END--- About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||